Gabapentin Capsule
Product Images NDC 63187-810

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63187-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-810 (Gabapentin 300mg Cap)

63187-810 (Gabapentin 300mg Cap)
Gabapentin 300 mg capsules, packaged by Proficient Rx LP, with product ID PG081015 and lot number 00000. Each capsule contains Gabapentin USP 300 mg and is yellow-colored, hard gelatin capsule with an imprint of "215" on the body with blue ink, with a serial number of SN# MASTER. The medication guide is included, and it is recommended to store the capsules at 20°-25°C (68°-77°F) and keep them out of reach of children. Manufactured by Alem Laboratories Ltd in Mumbai, India, and distributed by Proficient Rx in Thousand Oaks, CA 91320.*
FDA Label Image

Gabapentin-equation (Gabapentin Equation)

Gabapentin-equation (Gabapentin Equation)
This text appears to be a formula or equation that involves calculating a person's weight (in kilograms) multiplied by their serum creatinine level (in milligrams per deciliter). There is also a mention of a correction factor for female patients, but it is unclear how it is meant to be applied. It is not possible to provide a more detailed or accurate description without additional context or information.*
FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
This appears to be a report or study related to pain, possibly evaluating the effectiveness of different treatments. The chart shows a comparison of mean pain scores based on different treatment periods, including a fixed-dose period and a placebo group. Gabapentin is also mentioned as a treatment option with a high daily dosage. However, without more context or information, it is difficult to provide a more detailed description of the text.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

FDA Label Image

Gabapentin Structure (Gabapentin Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.